RSS Feeds
Search

Companies

Companies

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
FDA Withdraws Approval of Avastin in Breast Cancer
Jan 2011 - 4 pages - $500
Antihormonal Therapies Market Forecast
Jul 2010 - $15,200
Iniparib Failure: Highlights the Uncertainty in Late Stage Breast Cancer Pipeline
Mar 2011 - 5 pages - $500
Avastin and the AVADO Trial Survey
Feb 2008 - $2,500
Top 20 Cancer Therapy Brands in Australia Forecast
Mar 2010 - $5,700
Breast Cancer Drug Discoveries: what the future holds 2008: Chapter
Dec 2008 - 200 pages - $1,390
Turk Hava Yollari Anonim Ortakligi - SWOT Analysis
Feb 2011 - 26 pages - $125
Turk Telecom
Apr 2009 - 11 pages - $825
Spanish Breast Cancer Research Group – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Breast Cancer Global Clinical Trials Review, Q4, 2010
Oct 2010 - 100 pages - $1,000
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
Generics del
Therapeutic target
Oncology del
Breast cancer del
Geographic location
Central America del
Grand Turk Island del

Visit also genericlicensing.com

The website which helps the generic industry do business. Visit now

Browse By

Therapeutic target
Adenocarcinoma
Breast cancer, other
Ductal carcinoma in situ
Invasive ductal breast cancer
Invasive lobular breast cancer
Lobular carcinoma in situ
Paget's Disease

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us